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Macrophages are innate immune cells that adopt
diverse activation states in response to their micro-
environment. Editing macrophage activation to
dampen inflammatory diseases by promoting the
repolarization of inflammatory (M1) macrophages to
anti-inflammatory (M2) macrophages is of high
interest. Here, we find that mouse and human M1
macrophages fail to convert into M2 cells upon IL-4
exposure in vitro and in vivo. In sharp contrast, M2
macrophages are more plastic and readily repolar-
ized into an inflammatory M1 state. We identify
M1-associated inhibition of mitochondrial oxidative
phosphorylation as the factor responsible for pre-
venting M1/M2 repolarization. Inhibiting nitric
oxide production, a key effectormolecule inM1 cells,
dampens the decline in mitochondrial function to
improve metabolic and phenotypic reprogramming
to M2 macrophages. Thus, inflammatory macro-
phage activation blunts oxidative phosphorylation,
thereby preventing repolarization. Therapeutically
restoring mitochondrial function might be useful
to improve the reprogramming of inflammatory
macrophages into anti-inflammatory cells to control
disease.INTRODUCTION
In addition to their function in host defense, macrophages secure
tissue homeostasis and dampen inflammatory responses
(Okabe and Medzhitov, 2016; Wynn et al., 2013). To carry out
these seemingly contrasting functions, macrophages show
high plasticity and adopt a spectrum of polarization states,
among which M1 and M2 cells are the extremes (Xue et al.,684 Cell Reports 17, 684–696, October 11, 2016 ª 2016 The Author(s
This is an open access article under the CC BY-NC-ND license (http://2014). M1 macrophages are induced by the Th1 cytokine inter-
feron-g (IFNg) in combination with Toll-like receptor (TLR)
ligands, such as lipopolysaccharide (LPS), and they are, there-
fore, also termedM(LPS + IFNg) (Murray et al., 2014). These cells
secrete pro-inflammatory cytokines; produce reactive oxygen
and nitrogen species to ensure efficient microbial killing; and
show enhanced MHC-I/II, CD80, and CD86 expression. How-
ever, continuous M1 activation may cause collateral tissue
damage and chronic inflammation (Sica and Mantovani, 2012).
Macrophages are also activated by diverse non-inflammatory
factors. Although non-M1 macrophages are often grouped as
M2, the Th2 cytokines IL-4 and IL-13 are the only inducers of
the so-called alternatively activated macrophages (AAMs; M
[IL-4] and M2a) (Gordon and Martinez, 2010; Murray et al.,
2014; Sica and Mantovani, 2012). Functionally, M2 macro-
phages dampen Th1/M1-driven inflammation, promote tissue
repair, and mediate Th2-driven pathologies, such as asthma
and helminth infections. At themolecular level, M2macrophages
are characterized by a range of specific marker genes, surface
markers, and enzymes (Gordon and Martinez, 2010; Martinez
et al., 2013; Van den Bossche et al., 2009, 2012). For clarity,
we will hereafter refer to IL-4-induced macrophages as M2 and
to LPS + IFNg-elicited macrophages as M1 cells.
Editingmacrophage (re)polarization is emerging as a new ther-
apeutic approach (Hagemann et al., 2008; Sica and Mantovani,
2012; Wynn et al., 2013). For example, reprogramming tumor-
promoting M2-like tumor-associated macrophages into anti-tu-
morM1-like cells is being tested as a cancer treatment (Colombo
et al., 1992; Hagemann et al., 2008; Sica and Mantovani, 2012).
Conversely, the treatment of chronic inflammatory diseases,
such as atherosclerosis and rheumatoid arthritis, will benefit
from the repolarization of inflammatory M1 into anti-inflamma-
tory M2 macrophages. While the apparent switch from M1 to
M2 characterizes the course of repair and anti-microbial
responses (Das et al., 2015; Rigamonti et al., 2014; Van den Bos-
sche et al., 2009; Wynn et al., 2013), in vivo evidence of M1/M2
repolarization is lacking. Indeed, it is a continuing debate
whether the sequential presence of M1 and M2 macrophages).
creativecommons.org/licenses/by-nc-nd/4.0/).
Figure 1. LPS + IFNg-Primed Mouse M1 Macrophages Fail to Repolarize to M2 Cells upon IL-4 Restimulation
(A) To study the repolarization capacity of mouse bone marrow-derived macrophages (BMMs), normal M2 macrophages were compared to M1/M2 macro-
phages that were primed for 24 hr with LPS + IFNg before 24 hr IL-4 stimulation.
(B) The fold inductions of indicated IL-4-induced M2 marker genes are shown relative to the expression in untreated macrophages (= 1).
(C) Differentially treated macrophages were stained with antibodies against the M2 surface markers CD71 (TFR, transferrin receptor), CD206 (MRC1, mannose
receptor C type 1), CD301 (MGL1/2, macrophage galactose-binding lectin), or isotype control, followed by flow cytometric analysis. Representative histogram
graphs and corresponding surface expression quantifications (DMFI = [Median fluorescence intensity]positive staining – [Median fluorescence intensity]isotype staining)
are presented.
(D) Arginase activity in BMM lysates was measured and shown as units (U) enzymatic activity. Values represent mean ± SEM of three mice (*p < 0.05, **p < 0.01,
and ***p < 0.001; ns, not significant).results from actual repolarization as a response to the changing
microenvironment or from the recruitment of newmonocytes to a
repair-promoting local milieu (Das et al., 2015; Italiani and Bora-
schi, 2014; Rigamonti et al., 2014).
Metabolic cascades are increasingly recognized as character-
istics and controllers of macrophage activation (Galva´n-Pen˜a
and O’Neill, 2014; Jha et al., 2015; Ouimet et al., 2015). M1 cells
use glycolysis for rapid killing, whereas M2 macrophages rely
on mitochondrial oxidative phosphorylation (OXPHOS) for sus-
tained energy production (Cramer et al., 2003; Huang et al.,
2014; Tan et al., 2015; Tannahill et al., 2013; Vats et al., 2006).
These metabolic cascades do not only reflect macrophage
energy production but also directly dictate the phenotype. As
such, glycolysis drives inflammatory macrophage responses
(Cramer et al., 2003; Tannahill et al., 2013), and OXPHOS sup-
ports M2 activation (Tan et al., 2015; Vats et al., 2006).
Here, we show that M1 activation inhibits mitochondrial func-
tion, thereby impairing future IL-4-responses. Inhibiting induciblenitric oxide synthase (iNOS) in mouse macrophages dampened
the LPS + IFNg-induced decline in mitochondrial respiration
and improved the metabolic and phenotypic M1/M2
repolarization.
RESULTS
Mouse M1 Macrophages Fail to Repolarize to M2 upon
IL-4 Restimulation In Vitro
Given that the treatment of chronic inflammatory diseases could
profit from the repolarization of inflammatory into anti-inflamma-
tory macrophages, we assessed the repolarization capacity of
M1 cells. Hereto, we first compared the IL-4-induced response
of mouse bone marrow-derived macrophages (BMMs) that had
been pre-treated with LPS + IFNg (Figure 1A, cyan checkered)
with the response of normal M2 cells (cyan). Inflammatory
M1 macrophages did not exhibit efficient upregulation of the
M2-specific marker genes Cdh1 (E-cad), Chi3l3, Mrc1, andCell Reports 17, 684–696, October 11, 2016 685
Figure 2. Human Macrophages Show No M1/M2 Repolarization
(A) To study the plasticity of humanM1macrophages, peripheral bloodmonocyte-derivedmacrophages (MoDMs) were primed with LPS + IFNg or left untreated.
After 24 hr, cells were washed and treated with IL-4 for another 24 hr, or they remained untreated as a control. IL-4-induced M2macrophages were compared to
M1/M2 macrophages that were primed with LPS + IFNg before IL-4 treatment.
(B) The fold inductions of the indicated M2-associated genes are shown relative to the expression in untreated macrophages (= 1).
(C) (Re)polarized macrophages were stained with antibodies against CD14, CD23, CD200R, CD206, or isotype controls, followed by flow cytometric analysis.
Representative histogram overlays for differentially treated CD14+ macrophages, together with the quantified surface expression values (DMFI = [Median
fluorescence intensity]positive staining – [Median fluorescence intensity]isotype staining) are shown. Values represent mean ± SEM of three wells of one representative
donor (of three tested donors) (*p < 0.05, **p < 0.01, and ***p < 0.001; ns, not significant).Retnla, when the cells were washed and stimulated 30 min after-
ward with IL-4 for 24 hr (Figure 1B). Also, when the M1 cells were
allowed to recover for 24 hr between the first inflammatory
response and the subsequent M2 repolarization, IL-4 failed to
elicit an efficient M2 gene signature (Figure S1). In accordance
with the gene expression data, the M2 surface markers CD71,
CD206, and CD301 were not induced by IL-4 following LPS +
IFNg stimulation (Figure 1C). Despite the fact that Arg1 gene
expression was plastic and was still inducible by IL-4 after
LPS + IFNg stimulation (Figure 1B), M1/M2 macrophages
showed significantly less IL-4-induced arginase function
compared to M2 cells (Figure 1D). Likewise, LPS + IFNg pre-
treatment impaired the induction of an IL-10-elicited M2-like
phenotype (Figure S2).
Next, we studied the capacity of M2 macrophages to mount
an inflammatory response by comparing the LPS + IFNg-
induced response of M2/M1 (Figure S3A, red checkered)
with the response of normal M1 cells (red). We found that, inde-
pendent of the first stimulus, LPS + IFNg efficiently induced the
M1-associated genes Il12b, Il1b, Il6, Nos2, and Tnf in both
M2/M1 and M1 cells (Figure S3B). The repolarization capacity686 Cell Reports 17, 684–696, October 11, 2016of IL-4-inducedmacrophages was further reflected at the protein
level, as M2/M1 and M1 macrophages displayed identical
CD80 and CD86 expression (Figure S3C) Functionally,
M2/M1 and M1 macrophages showed similar inflammatory
cytokine secretion and iNOS-mediated nitric oxide (NO) pro-
duction (Figures S3D and S3E). Thus, while mouse M2 macro-
phages readily repolarized to a pro-inflammatory state upon
LPS + IFNg restimulation, M1 activation prevented subsequent
M2 polarization in vitro.
Human Inflammatory Macrophages Do Not Repolarize
to M2
To test the relevance of these findings for humans, we studied
the M1/M2 repolarization of peripheral blood monocyte-
derived human macrophages (MoDMs) (Figure 2A). Con-
firming our studies with mouse macrophages, human M1
macrophages showed strongly impaired IL-4-induced expres-
sion of the M2 marker genes CCL22, CCL24, CD200R,
CD206, and FCER2 (CD23) (Figure 2B). In accordance, the
M2 surface markers CD23, CD200R, and CD206 were not
induced by IL-4 after prior LPS + IFNg stimulation (Figure 2C).
Figure 3. Ex-Vivo-Stimulated M1 Macro-
phages Do Not Repolarize to M2 In Vivo in
Response to an IL-4 Challenge
(A) To assess in vivo M1/M2 repolarization after
IL-4 injection, BMMs from CD45.1 donor mice
were stimulated with LPS + IFNg (red) or left un-
treated (gray).
(B) After 24 hr, these CD45.1+ macrophages
were assessed for efficient M1 polarization,
and they were transferred to CD45.2 acceptor
mice that next received IL-4c (or PBS as a
control).
(C) After 48 hr, flow cytometry was performed on
the peritoneal cells to assess CD71, CD206, and
CD301 M2 surface marker expression on CD45.1+
F4/80+ adoptively transferred macrophages
(gate i). As such, M2 polarization (cyan bars) and
M1/M2 repolarization (cyan checkered bars)
were measured and presented as DMFI = (Median
fluorescence intensity)positive staining – (Median
fluorescence intensity)isotype staining. Values repre-
sent mean ± SEM of four mice (*p < 0.05,
**p < 0.01, and ***p < 0.001).Thus, both mouse and human macrophages completely failed
to accept an IL-4-induced state after a preceding inflamma-
tory stimulus.
Conversely, human IL-4-induced M2 cells reversed to an in-
flammatory state upon LPS + IFNg treatment, as evidenced by
the high expression of M1 marker genes and surface markers
and by the enhanced secretion of inflammatory cytokines (Fig-
ures S4A–S4D). Thus, while M2/M1 repolarization efficiently
occurred in both mouse and human macrophages, the opposite
M1/M2 conversion was impossible.
Inflammatory Macrophages Fail to Repolarize to M2
In Vivo
Next, we studied whether the M1/M2 repolarization defect
that we observed in vitro also has relevance in vivo. To
test this, untreated (N) or LPS + IFNg-treated (M1) BMMsCell Rfrom CD45.1+ donor mice were adop-
tively transferred intraperitoneally to
CD45.2+ acceptor mice, which next
received an intraperitoneal challenge
with IL-4c to induce M2 polarization
(Figure 3A). LPS + IFNg-treated macro-
phages showed strongly enhanced in-
flammatory cytokine secretion and NO
production (Figure 3B). Confirming our
mouse and human in vitro observations,
these M1-primed macrophages failed to
upregulate CD71, CD206, and CD301
M2 surface marker expression upon
in vivo IL-4 challenge (Figure 3C, cyan
checkered boxes). Demonstrating the
efficiency of this in vivo challenge
protocol, adoptively transferred naive
CD45.1+ macrophages (Figure 3C,
cyan) and CD45.2+-resident macro-phages (data not shown) efficiently upregulated the tested
M2 surface markers upon IL-4c administration.
Overall, we showed that M1 macrophages also failed to
convert into M2 cells upon an IL-4 challenge in vivo.
LPS + IFNg Treatment Blunts Mitochondrial Oxidative
Respiration in Mouse Macrophages
Next, we further studied mouse BMMs to identify why M1 cells
are unable to repolarize to M2. Because the minimum require-
ment for M1/M2 repolarization is an intact IL-4Ra-JAK-
STAT6 pathway, we first assessed IL-4Ra expression and
STAT6 phosphorylation. IL-4Ra levels were compared
among naive, LPS + IFNg-induced M1, IL-4-induced M2, and
M1/M2 macrophages (Figure 4A). M1 polarization actually
enhanced IL-4Ra levels and also M1/M2 repolarized macro-
phages had increased levels compared to M2. Accordingly,eports 17, 684–696, October 11, 2016 687
M1/M2 repolarized macrophages showed effective STAT6
phosphorylation (Figure 4B). When assessing the viability of
differentially stimulated macrophages, we observed a similar
percentage of annexin V propidium iodide (PI) living cells
under all tested conditions (Figure 4C). However, M1 macro-
phages were less active than naive and, especially, M2 cells in
the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bro-
mide (MTT) assay (Figure 4D).
Although this assay is often used to assess cell viability, it
actually measures succinate dehydrogenase activity and, thus,
mitochondrial function. Given identical annexin V PI staining
(Figure 4), the changes observed in the MTT assay suggest
metabolic differences in these macrophages. This prompted
us to assess the metabolic characteristics of (re)polarized mac-
rophages by extracellular flux analysis, particularly because
recent evidence shows that macrophage polarization requires
metabolic reprogramming (Galva´n-Pen˜a and O’Neill, 2014).
Changes in extracellular acidification rate (ECAR) in response
to glucose, oligomycin (OM), and 2-deoxyglucose (2-DG) injec-
tion were used to calculate all glycolysis parameters. In parallel,
OXPHOS characteristics were calculated from the changes in
oxygen consumption rate (OCR) in response to OM, carbonyl
cyanide 4-(trifluoromethoxy)phenylhydrazone (FCCP), and rote-
none (ROT) + antimycin A (AA) injection, as detailed in Figure S5.
We confirmed that M2 macrophages show enhanced OXPHOS
and have the capacity to switch to glycolysis whenmitochondrial
ATP production is blocked with OM (Figures 4E–4G). In contrast,
M1 macrophages exhibited increased glycolysis, complete
suppression of OXPHOS, and reduced fatty acid oxidation
(FAO) (Figures 4E–4H).
To gain insight into the mechanism of reduced mitochon-
drial oxygen consumption in M1 macrophages, we examined
the effect of LPS + IFNg on different established metabolic
readouts. Mitochondrial dysfunction in M1 cells was not
caused by an LPS + IFNg-mediated suppression of mitochon-
drial (and glycolysis) genes nor by a reduction of mitochon-
drial mass, as demonstrated alike by MitoTracker Green
staining and mtDNA/genomic DNA (gDNA) ratio (Figures
S6A–S6D). Also, the activity of citrate synthase, the pace-
maker enzyme of the Krebs cycle, was not impaired in M1
(Figure S6E). Next, we measured the activity of the individual
mitochondrial respiratory complexes I–IV (calculated as
described in Table S1), using an established extracellular
flux analysis protocol. LPS + IFNg treatment completely sup-
pressed complex I and II activity and dampened complex II
and IV activity partially (Figure 4I, red bars). Importantly, the
LPS + IFNg-mediated inhibition of the distinct electron trans-
port chain complexes could not be restored by subsequent
IL-4 restimulation (blue/white bars). Also, in intact cells, the
LPS + IFNg-mediated suppression of mitochondrial respira-
tion was not restored after subsequent IL-4 treatment, as
demonstrated by the highly suppressed basal respiration,
ATP synthase activity, maximal respiration, and spare respira-
tory capacity (calculated as described in Figure S5) observed
in M1/M2 cells compared with naive controls and normal M2
macrophages (Figure 4J). Thus, M1 macrophages failed to
repolarize to M2 cells phenotypically, functionally, and
metabolically.688 Cell Reports 17, 684–696, October 11, 2016Mitochondrial Function Is Required for the Induction of
an M2 Phenotype
Given that increasedmitochondrial metabolism is both a charac-
teristic of and requirement for the anti-inflammatory responses
of M2 macrophages (Huang et al., 2014; Tan et al., 2015; Vats
et al., 2006), the suppression of OXPHOS by LPS + IFNg may
impede M1/M2 repolarization. In support of this hypothesis,
blocking mitochondrial ATP synthase activity with OM before
IL-4 stimulation dampened OCRs (Figure 5A) and, thereby,
completely abolished IL-4-induced Arg1, Cdh1, Chi3l3, and
Retnla expression (Figure 5B). In the absence of mitochondrial
ATP production, these macrophages relied on increased glycol-
ysis to fulfill their energy demands (Figure 5A). Depending on the
situation, both glucose and FAO can fuel mitochondrial function
in M2macrophages (Huang et al., 2014; Namgaladze and Br€une,
2014; Tan et al., 2015; Vats et al., 2006). In the settings tested in
the present study, 2-DG-mediated blocking of the glycolytic flux
suppressed mitochondrial respiration (Figure 5A) and impaired
M2-associated gene expression (Figure 5B). While FAO was
suppressed by LPS + IFNg stimulation (Figure 4H), inhibiting
FAO with etomoxir (ETO) did not prevent the induction of most
M2-associated genes (Figure 5B). Confirming our gene expres-
sion data, macrophages pre-treated with 2-DG and, especially,
OM exhibited a reduction of IL-4-induced CD71, CD206, and
CD301 expression and arginase-1 activity (Figures 5C and 5D).
Overall, these experiments showed that LPS + IFNg inhibited
glucose-fueled mitochondrial respiration, thereby trapping
macrophages in a metabolic state that prevented future IL-4-
induced polarization.
NO Blunts Mitochondrial Respiration and Prevents
Plasticity in M1 Macrophages
Next, we aimed to identify the mechanism underlying the LPS +
IFNg-induced decline in mitochondrial function and prevention
of future IL-4 responses. M1 cells display various features that
could impede mitochondrial function and M1/M2 repolariza-
tion. First, if the macrophage metabolic machinery itself lacks
plasticity, the induction of glycolysis by LPS + IFNgmight impair
subsequent IL-4-induced reprogramming toward OXHPOS.
Moreover, as an antimicrobial mechanism, M1 cells produce
reactive oxygen species (ROS) and iNOS-generated NO, which
both inhibit mitochondrial function in other cell types (Everts
et al., 2012; Raza et al., 2014).
To assess these alternatives, we pre-treated macrophages
with the glycolysis inhibitor 2-DG, the ROS scavenger N-acetyl-
cysteine (NAC), or the iNOS inhibitor 1400W (Garvey et al., 1997),
followed by LPS + IFNg treatment (Figures 6A–6D). Only iNOS
inhibition markedly improved mitochondrial function in M1
macrophages, as demonstrated by a pronounced increase in
basal respiration, mitochondrial ATP production, and maximal
respiration in 1400W-pre-treated M1 cells (Figure 6E). While
scavenging ROS with NAC did not improve mitochondrial
function, 2-DG-treated M1 macrophages showed a slight in-
crease in mitochondrial ATP production, possibly caused by
the 2-DG-mediated inhibition of LPS + IFNg-induced NO
production (Figures 6D and 6E).
Because iNOS inhibition dampened the LPS + IFNg-induced
decline in mitochondrial function, we next tested whether this
Figure 4. LPS + IFNg Treatment Impairs OXPHOS and This Effect Cannot Be Reserved by IL-4 upon Repolarization
To study why M1macrophages do not repolarize to M2 cells, we first assessed IL-4Ra/STAT6 signaling and cell viability in M1, M2, and M1/M2macrophages.
(A) A representative IL-4a histogram and corresponding quantifications (DMFI = [Median fluorescence intensity]positive staining – [Median fluorescence
intensity]isotype staining) are depicted.
(B) Cell lysates were immunoblotted with antibodies against p-STAT6 or actin.
(legend continued on next page)
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Figure 5. M2 (Re)polarization Needs Glucose-Fueled OXPHOS
For all assays, BMMs were pre-treated with OM, 2-DG, or etomoxir (ETO) or left untreated, followed by IL-4 stimulation in the presence of the inhibitors.
(A) Basal OCR and ECAR rates were measured by extracellular flux analysis as a measurement for OXPHOS and glycolysis, respectively.
(B) The gene expression levels of indicated IL-4-induced M2 marker genes are shown relative to the expression in untreated macrophages (= 1).
(C) BMMs were stained with antibodies against the M2 surface markers CD71 (TFR), CD206 (MRC1), CD301 (MGL1/2), or isotype control, followed by flow
cytometric analysis. Representative histogramplots, together with the quantified surface expression values (DMFI = [Median fluorescence intensity]positive staining –
[Median fluorescence intensity]isotype staining), are shown.
(D) Arginase activity in BMM lysates was calculated and plotted as units (U) enzymatic activity. Values represent mean ± SEM of three mice (*p < 0.05, **p < 0.01,
and ***p < 0.001; ns, not significant).strategy also could promote future IL-4 responses. For this
purpose, we performed repolarization experiments in the pres-
ence of the iNOS inhibitor 1400W. iNOS inhibition during the
first LPS + IFNg response markedly improved subsequent
IL-4-induced metabolic reprogramming toward enhanced
OXPHOS. Indeed, 1400W-pre-treated M1/M2 macrophages
showed significantly higher basal respiration, ATP production,(C) BMMs were subjected to Annexin V plus PI staining to determine the percen
(D) MTT assay was performed to measure mitochondrial succinate dehydrogena
(E–G) BMMs were seeded in Seahorse plates and stimulated for 24 hr. During e
gomycin (OM), and 2-deoxyglucose (2-DG), to determine glycolysis parameters fro
(AA), to assess OXPHOS parameters from the OCR levels. (G) All calculated m
macrophages (N = 100%).
(H) Fatty acid oxidation (FAO) rates in naive, M1, and M2 macrophages were mea
function in polarized and repolarized macrophages, BMMs were treated as indic
(I) Plasma membrane-permeabilized macrophages were provide with a cockta
IV-mediated respiratory activity. Data were plotted as OCR in pmoles/min.
(J) Using intact cells, the basal respiration, mitochondrial ATP production, maxima
as OCR in pmoles/min. Values represent mean ± SEM of three mice (*p < 0.05, *
690 Cell Reports 17, 684–696, October 11, 2016and maximal respiration compared with M1/M2 macro-
phages in which iNOS was not inhibited (Figure 6F). Accord-
ingly, iNOS inhibition improved the activity of complexes I–IV
of the electron transport chain in M1/M2 repolarized macro-
phages, as demonstrated by extracellular flux analysis on
permeabilized macrophages and by the MTT assay (Figures
6G and 6H).tage of AV PI viable cells.
se activity.
xtracellular flux analysis, cells were sequentially treated with (E) glucose, oli-
m the ECAR levels, or with (F) OM, FCCP, and rotenone (ROT) plus antimycin A
etabolic parameters in M1 and M2 cells are shown relative to those in naive
sured as described previously (Zhang et al., 2012). To compare mitochondrial
ated, followed by OCR measurement.
il of specific substrates and inhibitors to measure complex I-, II-, III-, and
l respiration, and spare respiratory capacity (SRC) were calculated and plotted
*p < 0.01, and ***p < 0.001; ns, not significant).
Figure 6. iNOS Inhibition Improves OXPHOS and M1 to M2 Repolarization
(A–D) Macrophages were pre-treated with glycolysis inhibitor 2-DG, ROS scavenger NAC, or iNOS inhibitor 1400W, followed LPS + IFNg treatment in the
presence of the compounds. To demonstrate the respective efficacy of the distinct compounds, wemeasured (A) glycolysis as extracellular acidification (ECAR),
(B) ROS with DCFDA, (C) oxidative stress with CellROX, and (D) NO production.
(E) OXPHOS parameters were assessed by recording the OCR values after sequential injection of OM, FCCP, and ROT + AA. Calculated basal respiration, ATP
production, and maximal respiration were plotted in bar graphs.
(legend continued on next page)
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Importantly, the repair of mitochondrial function via iNOS inhi-
bition was sufficient to significantly improve the repolarization
capacity of M1 cells. As such, iNOS inhibition during the first
M1 polarization improved the phenotypic plasticity of the cells,
as demonstrated by the enhancement of IL-4-induced CD71,
CD206, andCD301 expression in thesemacrophages (Figure 6I).
iNOS inhibition had no effect on M2 polarization, as pre-treat-
ment with 1400W did not affect the IL-4-induced expression of
M2-associated genes and surface markers (Figure S7A). More-
over, the enhanced plasticity of 1400W-pre-treated M1 macro-
phages was effectively due to the iNOS inhibitory effect of
1400W and not to overall inhibition of the first LPS + IFNg
response. Indeed, 1400W did not block MHC-II, CD80, and
CD86 expression (Figure S7B) or inflammatory cytokine secre-
tion (Figure S7C). Thus, iNOS inhibition did not affect M1 and
M2 polarization per se but improved M1/M2 repolarization.
Confirming these assays, Nos2/ macrophages showed
improved M1/M2 phenotypic repolarization, associated with
improved mitochondrial respiration. Evidently, Nos2/ macro-
phages did not produce NO, but exhibited normal M1 and M2
polarization (Figures S8A–S8F) Thus, NO impeded M1/M2
repolarization, but did not affect M1 andM2 polarization as such.
DISCUSSION
Distinct arginine metabolism was one of the first characteristics
employed to define macrophage subsets (Munder et al., 1998).
M1 cells convert arginine into NO through iNOS activity and
are crucial for host defense. However, sustained M1 activation
can cause tissue damage and chronic inflammation. Therefore,
a repair phase has to be initiated in which M2 cells predominate.
As the yin to the yang of M1, M2 macrophages are low in iNOS,
show high arginase-1 activity, and promote tissue repair and res-
olution of inflammation (Van den Bossche et al., 2012). As such,
the course of infections and healing responses is often charac-
terized by an apparent switch from M1 to M2 polarization (Das
et al., 2015; Rigamonti et al., 2014; Van den Bossche et al.,
2009). This transition can be caused by actual reprogramming
of macrophages and/or replacement of M1 cells with recruited
monocytes that differentiate into M2 under the influence of the
newly established environment (Das et al., 2015). Reshaping un-
balanced macrophage polarization has been suggested as the
holy grail of macrophage therapeutic targeting (Sica and Manto-
vani, 2012). In support of this notion, reversal of M2-like tumor-
associated macrophages into tumor-killing phagocytes has
been used with great success in cancer therapy (Allavena
et al., 1990; Colombo et al., 1992; Hagemann et al., 2008).
We now show that M2 macrophages are indeed highly plastic
and easily adopt an M1-like inflammatory state. In sharp(F) Similarly, OXPHOS inM1/M2 repolarizedmacrophages (pre-treated or not wi
normal M2 cells.
(G) Complex I-, II-, III-, and IV-mediated OCR values were measured in plasma m
(H) Mitochondrial succinate dehydrogenase activity in differentially treated macr
(I) The phenotypic M1/M2 repolarization of normal M1 cells and M1 macrophag
CD206, and CD301 in comparison to the levels in normal M2 macrophages. Repr
[Median fluorescence intensity]positive staining – [Median fluorescence intensity]isoty
**p < 0.01, and ***p < 0.001; ns, not significant).
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and in vivo, as demonstrated by strongly reduced M2-associ-
ated gene and surface protein expression. In support of our
findings, previous studies have shown that in vitro IFNg priming
dampens successive IL-4-induced expression of multiple
M2-associated genes (Davis et al., 2013; Khallou-Laschet
et al., 2010). Furthermore, from a functional perspective,
M1/M2 repolarized macrophages showed aberrant arginase
activity and strongly impaired OXPHOS. Importantly, our thor-
ough phenotypic, functional, and metabolic characterization
supports our findings of irreversibility of M1/M2 polarization.
If only the Nos2/Arg1 balance were employed as a readout for
M1/M2, we would have incorrectly concluded that both M1
and M2 macrophages are fully reversible. Indeed, confirming
previous data (Davis et al., 2013), Arg1 was the only M2-associ-
ated gene that was still fully induced by IL-4 after prior LPS +
IFNg treatment. Otherwise, M1 cells completely failed to repo-
larize to M2 macrophages.
We found that the metabolic characteristics of M1 cells pre-
vented repolarization to anM2 state. Inhibiting OXPHOS through
LPS + IFNg stimulation or via OM-mediated inhibition of ATP
synthesis completely abolished M2 (re)polarization. Mitochon-
drial respiration was mainly fueled by glycolysis and not by
FAO. These data contribute to the current opinion that the effect
of ETO on M2 polarization is more complicated than previously
envisioned (Huang et al., 2014; Namgaladze and Br€une, 2014;
Tan et al., 2015; Vats et al., 2006). Confirming our observations,
a very recent study applied a genetic strategy to disrupt FAO in
macrophages and showed no role for FAO in M2 polarization
(Nomura et al., 2016).
Our data support the idea that inflammatory triggers
induce glycolysis to rapidly provide energy for the clearance of
intracellular pathogens by ROS and NO. We now show that, as
a consequence of this respiratory burst, LPS + IFNg induces
mitochondrial dysfunction that cannot be restored by subse-
quent IL-4 stimulation, thereby directly hampering M1/M2
repolarization. Inhibiting LPS + IFNg-induced NO production
reduced mitochondrial dysfunction and improved phenotypic
and metabolic M1/M2 repolarization. NO and NO-derived
reactive nitrogen species can inactivate all iron-sulfur-containing
complexes of the mitochondrial electron transport chain (Brown
and Borutaite, 2007; Che´nais et al., 2002; Pearce and Pearce,
2013). We found LPS + IFNg to decrease mainly complex I and
complex II activity, with minor effects on complexes III and IV.
This decline could not be reversed by IL-4, but it was at least
partially prevented by iNOS inhibition.
To overcome mitochondrial dysfunction, glycolysis is neces-
sary to maintain ATP production in NO-producing dendritic cells
(Everts et al., 2012). It has been suggested that increasedth the iNOS inhibitor 1400W)was assessed and compared to the OCR values in
embrane-permeabilized macrophages and plotted in pmoles/min.
ophages was measured using an MTT assay.
es with inhibited iNOS was assessed by flow cytometry for M2 markers CD71,
esentative histograms, together with the quantified expression values (DMFI =
pe staining), are shown. Values represent mean ± SEM of three mice (*p < 0.05,
glycolysis in inflammatory macrophages is mainly caused by
reactive nitrogen species (Albina and Mastrofrancesco, 1993).
However, our data demonstrate that the enhanced glycolysis
observed in M1 cells is not simply a consequence of NO produc-
tion and associated mitochondrial dysfunction. In fact, LPS +
IFNg treatment in the presence of the iNOS inhibitor induces
even higher glycolysis, emphasizing that additional factors,
such as HIF1a and PKM2, cooperate to induce glycolysis in
M1 macrophages (Izquierdo et al., 2015; Palsson-McDermott
et al., 2015). The reason why iNOS inhibition induces glycolysis
remains unstudied, but it might be attributable to glyceralde-
hyde-3-phosphate dehydrogenase activation. Indeed, NO
induces ADP ribosylation of this glycolytic enzyme and thereby
inhibits its activity (Dimmeler and Br€une, 1993).
Although iNOS inhibition clearly improved mitochondrial
function in M1 cells, it only partially restoredM1/M2 repolariza-
tion, highlighting the existence of additional mechanisms
that prevent the conversion of inflammatory macrophages into
anti-inflammatory cells. In support of this notion, human M1
macrophages did not secrete NO in vitro (data not shown),
and, thus, additional unidentified mechanisms are clearly at
play that prevent M1/M2 repolarization in mice and humans.
Possibly itaconate contributes to the suppression of mitochon-
drial function in inflammatory macrophages. This antibacterial
product is highly induced by inflammatory stimuli in both mouse
and humanmacrophages, and it has been reported to impair the
activity of complex II of the electron transport chain (Meiser et al.,
2016; Michelucci et al., 2013; O’Neill and Pearce, 2016). In
patients, however, iNOS+ macrophages are present in a variety
of inflammatory diseases, and NO might therefore also impair
M1/M2 repolarization in vivo in humans (Bingisser and Holt,
2001; Sto¨ger et al., 2012; Thomas and Mattila, 2014).
Our findings support the earlier notion that M1 macrophages
are end-stage killer cells (Italiani and Boraschi, 2014). Accord-
ingly, neutrophils show an M1-like metabolism with high glycol-
ysis and low OXPHOS. Their metabolism underlies the uniting
characteristic of granulocytes, and these inflammatory phago-
cytes are short lived and terminally differentiated (Pearce and
Pearce, 2013). Indeed, M1 cells failed to adopt anM2 phenotype
during an IL-4 challenge in vivo. These observations imply that
the apparent switch from M1 to M2 macrophages during the
course of infection or healing responses is probably not caused
by actual M1/M2 repolarization of the macrophages that are
present, but rather by the repopulation and M2 polarization of
newly recruited blood monocytes in the healing-promoting
environment, as suggested previously (Italiani and Boraschi,
2014). The observation that inhibition or deletion of iNOS
improves M1/M2 repolarization, without affecting M1 or M2
polarization as such, could help to explain previous in vivo
findings in Nos2/ mice. Indeed, improved reprogramming of
pro-atherogenic M1 cells to inflammation-resolving, pro-fibrotic
M2 macrophages may underlie the decreased atherosclerosis
(Kuhlencordt et al., 2001) and increased atherosclerotic collagen
deposition (Niu et al., 2001) observed in Nos2/ mice.
Our thorough metabolic characterization of polarized and re-
polarized macrophages not only explains why M1 cells fail to
repolarize toM2 but also simultaneously clarifies whyM2macro-
phages are highly plastic and readily repolarize to M1. Indeed,while exhibiting amodest basal glycolytic rate, M2macrophages
display high glycolytic reserves and immediately switch to high
glycolysis after mitochondrial ATP production is blocked. How
mitochondrial oxidative metabolism supports IL-4-induced
polarization, as demonstrated here and by others (Tan et al.,
2015; Vats et al., 2006), remains elusive and deserves further
investigation. In this context, we are currently investigating
how metabolic changes affect metabolite availability for epige-
netic enzymes and, through epigenetic remodeling, influence
M1- and M2-associated gene expression (Baardman et al.,
2015).
Overall, the present study demonstrates that M1 activation of
macrophages blunts OXPHOS, thereby preventing their repolar-
ization to M2. Restoring mitochondrial function, for example,
through iNOS inhibition, might be useful to improve the reprog-
ramming of M1 into M2 macrophages as a method of controlling
inflammatory diseases.
EXPERIMENTAL PROCEDURES
Mice
Wild-type C57BL/6J(c) and B6.SJL-Ptprca Pepcb/BoyJ (CD45.1+) 8- to
16-week-old mice were obtained from Charles River Laboratories, and bone
marrow of Nos2/ mice (B6.129P2-Nos2tm1Lau/J) was a gift from Claude
Libert (VIB, Ghent University). All experiments were approved by the Commit-
tee for Animal Welfare (University of Amsterdam).
Macrophage Cultures
Mouse bone marrow cells were isolated and cultured in RPMI-1640 with
2 mM L-glutamine, 10% fetal calf serum (FCS), penicillin (100 U/mL), strep-
tomycin (100 mg/mL) (Gibco), and 15% L929-conditioned medium. Human
peripheral mononuclear blood cells were isolated from healthy donors by
density centrifugation using Lymphoprep (Axis-Shield). Next, monocytes
were purified by magnetic-activated cell separation using human anti-
CD14 beads and LS separation columns (Miltenyi). Cells were cultured in
Iscove’s modified Dulbecco’s medium (IMDM, Life Technologies) with
10% FCS, penicillin (100 U/mL), streptomycin (100 mg/mL) (Gibco), and
25 ng/mL human macrophage-colony stimulating factor (M-CSF, Miltenyi)
at 106 cells/mL. On day 6, cells were harvested, seeded at 106 cells/mL,
and stimulated 24 hr with 10 U/mL IFNg (PeproTech) + 10 ng/ml LPS
(Sigma-Aldrich) or 100 U/mL IL-4 (Peprotech) to elicit M1 or M2 cells, respec-
tively. The 100 U/mL IL-10 (PeproTech) was used to elicit another type of
M2-like macrophage. For repolarization, BMMs were primed with IL-4 or
LPS + IFNg or they were left untreated. After 24 hr, cells were washed and
treated with the opposing stimulus for another 24 hr. OM (2 mM), 2-DG
(1 mM), ETO (50 mM), 1400W (100 mM), or NAC (5 mM) (all Sigma-Aldrich)
was added 30 min before macrophage activation.
In Vivo Macrophage (Re)polarization
To assess in vivo M1/M2 repolarization after IL-4 injection, BMMs from
CD45.1 donor mice were stimulated ex vivo with LPS + IFNg or left untreated.
After 24 hr, these CD45.1+ macrophages were harvested, washed in PBS,
counted, analyzed for their M1 phenotype, and injected (2.5 3 106 cells per
mouse) intraperitoneally into C57BL/6J(c) (CD45.2+) acceptor mice that next
received IL-4 (or PBS as control). To optimize the effect of IL-4, it was admin-
istered as an IL-4/anti-IL-4 complex (IL-4c), consisting of 5 mg recombinant
mouse IL-4 (PeproTech) and 25 mg 11B11 anti-IL-4 (BioConnect) in 100 ml
PBS, as described previously (Jenkins et al., 2013). Then 48 hr after the IL-4
challenge, peritoneal cells were collected and analyzed by flow cytometry.
Gene Expression Analysis
RNA was isolated with High Pure RNA Isolation kits (Roche), cDNA was
synthesized with iScript (Bio-Rad), and qPCR was performed using Sybr
Green Fast mix (Applied Biosytems) on a ViiA7 (Applied Biosystems).Cell Reports 17, 684–696, October 11, 2016 693
Housekeeping genes Rplp0 (Arbp) and Ppia were used for normalization.
Primer sequences are available upon request.
Flow Cytometry
Cells were pre-incubated with Fc-block followed by the labeling antibodies
listed in Table S2. Cell viability was assessed by PI/Annexin V-Alexa-Fluor647
staining according to the manufacturer’s protocol (Invitrogen). Data were
acquired with a FACSCantoII (Becton Dickinson) and analyzed using FlowJo
(Tree Star). Surface expression was calculated as DMFI = (Median fluores-
cence intensity)positive staining – (Median fluorescence intensity)isotype staining.
Macrophage Function
IL-6, IL-12(p40), and TNF were quantified by ELISA in accordance with the
supplier’s protocols (Life Technologies). NO production was measured by
NO2
 quantification in a Griess reaction (Sigma-Aldrich). 2’,7’ –dichlorofluor-
escin diacetate (DCFDA) was used to measure ROS and oxidative stress
was measured with CellROX (both Thermo Fisher Scientific). Arginase
activity (1 U = amount of enzyme that catalyzes the formation of 1 mmol
urea/min/106 cells) was assessed as described previously (Van den Bossche
et al., 2012).
Immunoblotting
BMM lysates were separated on a NuPAGE Novex 4%–12% Bis-Tris gel
(Thermo Fisher Scientific) and transferred onto nitrocellulose membrane
(Bio-Rad). After blocking, membranes were incubated with primary antibodies
(Table S2), followed by incubation with horseradish peroxidase (HRP)-conju-
gated secondary antibodies and visualization using the SuperSignal West
Pico Chemiluminescent Substrate (Thermo Fisher Scientific).
MTT Assay
Succinate dehydrogenase activity was assessed by yellow MTT reduction
into purple formazan. Macrophages were incubated with 1 mg/mL MTT
(Sigma-Aldrich) for 3 hr, lysed with 0.1 N HCl in isopropanol, and the released
solubilized formazan was measured spectrophotometrically and compared to
the levels in naive macrophages (N = 100%).
Metabolic Extracellular Flux Analysis
BMMs (25,000) were plated in XF-96-cell culture plates (Seahorse Bioscience)
and treated as indicated. ECARs and OCRs were measured in an XF-96 Flux
Analyzer (Seahorse Bioscience) as described previously (Van den Bossche
et al., 2015). Changes in ECAR in response to glucose, OM, and 2-DG injection
were used to calculate all glycolysis parameters, and OXPHOS characteristics
were calculated from the OCR changes in response to OM, FCCP, and ROT +
AA injection, as detailed in Figure S3. FAO was measured as described
previously (Zhang et al., 2012). In brief, 200 mM palmitate-BSA complex was
injected into XF-96-cell culture plates containing naive, M1, or M2
macrophages. Next, the fraction of OCR attributed to palmitate
oxidation was determined by ETO (100 mM) injection and calculated as
FAO = OCRbefore ETO – OCRafter ETO. The activity of the individual mitochondrial
respiratory complexes I–IV was measured using an established protocol
(Salabei et al., 2014). In brief, plasma membrane-permeabilized (PMP) macro-
phages were treated with a cocktail of specific substrates and inhibitors
(all from Sigma-Aldrich; Table S1) to measure complex I-, II-, III-, and IV-medi-
ated OCR. On completion of the distinct Seahorse experiments, DNA content
was measured with CyQuant to normalize ECAR and OCR data.
Statistics
Data were evaluated with GraphPad Prism 4 using one-way ANOVA.
Unless otherwise stated, values represent the mean ± SEM of three
replicates of one representative experiment (*p < 0.05, **p < 0.01, and
***p < 0.001).
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